IPO
-
-
-
-
-
-
-
Intellia Therapeutics Announces Third Quarter 2017 Financial Results
-
-
-
-
-
-
-
CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Provide Update on CRISPR/Cas9 U.S. Patent Interference Proceedings and Grants of Corresponding Patents in the U.K.
-
-
-
-
-
-
-
Intellia Therapeutics (NTLA) IPO Opens 21% Higher
-
-
99,584 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All